EMS Sigma Farma

EMS is Brazil's largest pharmaceutical company and a leader in the Latin American market, specializing in the development, manufacturing, and commercialization of generic, branded, and over-the-counter (OTC) medicines. The company operates through several business units, including Sigma Pharma, which focuses on prescription-driven products across various therapeutic areas such as cardiology, gastroenterology, and orthopedics. EMS maintains a robust manufacturing infrastructure with state-of-the-art facilities capable of producing a wide range of dosage forms, including solids, liquids, and semi-solids. In recent years, the company has significantly invested in biotechnology and high-complexity medicines through its participation in the Bionovis joint venture. With a strong emphasis on research and development, EMS continues to expand its international footprint, exporting products to dozens of countries worldwide.